These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22147526)

  • 1. Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in mice.
    Shui G; Bendt AK; Jappar IA; Lim HM; Laneelle M; Hervé M; Via LE; Chua GH; Bratschi MW; Zainul Rahim SZ; Michelle AL; Hwang SH; Lee JS; Eum SY; Kwak HK; Daffé M; Dartois V; Michel G; Barry CE; Wenk MR
    EMBO Mol Med; 2012 Jan; 4(1):27-37. PubMed ID: 22147526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xpert
    Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults.
    Wilson D; Nachega J; Morroni C; Chaisson R; Maartens G
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):31-8. PubMed ID: 16466034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid method for Mycobacterium tuberculosis identification using electrospray ionization tandem mass spectrometry analysis of mycolic acids.
    Szewczyk R; Kowalski K; Janiszewska-Drobinska B; Druszczyńska M
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):298-305. PubMed ID: 23669043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mycolic acid forms using surface-enhanced Raman scattering as a fast detection method for tuberculosis.
    Perumal J; Dinish US; Bendt AK; Kazakeviciute A; Fu CY; Ong ILH; Olivo M
    Int J Nanomedicine; 2018; 13():6029-6038. PubMed ID: 30323590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.
    Cox HS; Mbhele S; Mohess N; Whitelaw A; Muller O; Zemanay W; Little F; Azevedo V; Simpson J; Boehme CC; Nicol MP
    PLoS Med; 2014 Nov; 11(11):e1001760. PubMed ID: 25423041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa.
    Murphy RA; Marconi VC; Gandhi RT; Kuritzkes DR; Sunpath H
    PLoS One; 2012; 7(9):e44793. PubMed ID: 23028623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.
    Schwander SK; Dietrich M; Mugyenyi P; Kityo C; Okwera A; Johnson J; Nsubuga P; Ruesch-Gerdes S; Whalen C
    East Afr Med J; 1997 Sep; 74(9):543-8. PubMed ID: 9487427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
    Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
    Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and antiretroviral effectiveness of concomitant use of rifampicin and efavirenz for antiretroviral-naive patients in India who are coinfected with tuberculosis and HIV-1.
    Patel A; Patel K; Patel J; Shah N; Patel B; Rani S
    J Acquir Immune Defic Syndr; 2004 Sep; 37(1):1166-9. PubMed ID: 15319677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel application of affinity biosensor technology to detect antibodies to mycolic acid in tuberculosis patients.
    Thanyani ST; Roberts V; Siko DG; Vrey P; Verschoor JA
    J Immunol Methods; 2008 Mar; 332(1-2):61-72. PubMed ID: 18207158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
    Khalil KF; Butt T
    J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the Centers for Disease Control and Prevention. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.
    JAMA; 1996 Nov; 276(19):1546. PubMed ID: 8918842
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycolic acids and ancient DNA confirm an osteological diagnosis of tuberculosis.
    Gernaey AM; Minnikin DE; Copley MS; Dixon RA; Middleton JC; Roberts CA
    Tuberculosis (Edinb); 2001; 81(4):259-65. PubMed ID: 11584593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin-monoresistant Mycobacterium tuberculosis disease among children in Cape Town, South Africa.
    Dramowski A; Morsheimer MM; Jordaan AM; Victor TC; Donald PR; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):76-81. PubMed ID: 22236850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of anti-mycolic acid antibody at self-assembled mycolic acid antigens on a gold electrode: a potential impedimetric immunosensing platform for active tuberculosis.
    Mathebula NS; Pillay J; Toschi G; Verschoor JA; Ozoemena KI
    Chem Commun (Camb); 2009 Jun; (23):3345-7. PubMed ID: 19503865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Okwera A; Nsubuga P; Nakibali JG; Whalen CC; Hom D; Cave MD; Yang ZH; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1032-40. PubMed ID: 11092715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis.
    Gengiah TN; Holford NH; Botha JH; Gray AL; Naidoo K; Abdool Karim SS
    Eur J Clin Pharmacol; 2012 May; 68(5):689-95. PubMed ID: 22108776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
    Cox HS; McDermid C; Azevedo V; Muller O; Coetzee D; Simpson J; Barnard M; Coetzee G; van Cutsem G; Goemaere E
    PLoS One; 2010 Nov; 5(11):e13901. PubMed ID: 21085569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.